Shri Ahimsa Naturals IPO listed at ₹140 on the NSE SME platform, marking a 17.65% premium over its issue price of ₹119. The strong debut highlights robust investor interest in the company.
Shri Ahimsa Naturals IPO saw strong demand, closing with an overall subscription of 62.71 times on March 27, 2025. The Qualified Institutional Buyers (QIB) portion was subscribed 21.23 times, Non-Institutional Investors (NII) at 182.82 times, and Retail Individual Investors (RII) at 35 times. The IPO witnessed a surge in interest on the final day, reflecting strong investor confidence.
Shri Ahimsa Naturals SME IPO had a last reported GMP of ₹19.5, with an estimated listing price of ₹138.5 based on the issue price of ₹119. However, the stock debuted at ₹140 on the NSE SME platform, slightly exceeding the GMP-based expectation. This resulted in an actual listing gain of 17.65%, compared to the estimated 16.39%, indicating stronger-than-expected demand.
Overview of Contents
Details About Shri Ahimsa Naturals IPO
Shri Ahimsa Naturals SME IPO is a book-built issue aiming to raise ₹73.81 crores, consisting of a fresh issue of 42.04 lakh shares worth ₹50.02 crores and an offer for sale (OFS) of 19.99 lakh shares totaling ₹23.79 crores. The IPO price band is ₹113-₹119 per share, with a minimum lot size of 1,200 shares, requiring an investment of ₹1,35,600. High-net-worth individuals (HNI) must bid for at least 2 lots (2,400 shares), amounting to ₹2,85,600. Given the possibility of oversubscription, investors are advised to bid at the cutoff price, which could reach ₹1,42,800 per lot. The IPO allocation is structured as 50% for QIBs, 15% for NIIs, and 35% for retail investors.
Shri Ahimsa Naturals Limited, incorporated in 1990, is engaged in the extraction and manufacturing of natural caffeine, green coffee bean extracts (GCE), and crude caffeine. The company supplies its products to industries such as food & beverage, nutraceuticals, cosmetics, and pharmaceuticals. It sources crude caffeine from Vietnam and Mexico and has also been processing caffeine from coffee and tea waste since 2022.
The company exports to over 14 countries, including the USA, Germany, South Korea, the UK, and Thailand. In FY24, Shri Ahimsa Naturals reported revenue of ₹7,463.71 lakhs, with exports contributing ₹3,530.91 lakhs. Its manufacturing unit in Jaipur, Rajasthan, is ISO-certified and follows GMP and HACCP guidelines. With an experienced management team and strong client relationships, the company aims for long-term growth.
Shri Ahimsa Naturals IPO Funds Deployment
- Investment in a fully-owned subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL).
- Establishment of a manufacturing facility at Sawarda, Jaipur, Rajasthan.
- Allocation for general corporate purposes related to the new setup.
Shri Ahimsa Naturals IPO Financial Performance
Shri Ahimsa Naturals has shown consistent financial growth, with total assets rising from ₹40.34 crore in FY22 to ₹111.39 crore as of Sep 30, 2024. While total revenue fluctuated, peaking at ₹106.14 crore in FY23, it stood at ₹41.37 crore for H1 FY25. Net profit followed a similar trend, reaching ₹38.21 crore in FY23 before settling at ₹9.74 crore in H1 FY25. Net worth has steadily increased to ₹99.67 crore, supported by growing reserves of ₹80.54 crore. The company’s total debt has significantly reduced from ₹13.83 crore in FY24 to ₹4.85 crore, indicating improved financial stability.